Dr. Sydney Burwell, Dean of Harvard Medical School 1956

My students are dismayed when I say to them "Half of what you are taught as medical students will in 10 years have been shown to be wrong.
And the trouble is, none of your teachers know which half."



Wednesday, November 6, 2013

Neoplasms

Cancer Development, Progression, and Therapy: An Epigenetic Overview
Epigenetic drugs may inhibit both the formation and growth of cancer progenitor cells, thus reducing the recurrence of cancer. Adopting epigenetic alteration as a new hallmark of cancer is a logical and necessary step that will further encourage the development of novel epigenetic biomarkers and therapeutics. Sarkar S, Horn G, Moulton K, Oza A, Byler S, Kokolus S, Longacre M. Int J Mol Sci. 2013 Oct 21;14(10):21087-113. PMID: 24152442

Statin use linked to lower prostate cancer death risk
Prostate cancer patients who take the cholesterol-lowering drugs known as statins appear to face a lower risk of death from their disease, new Canadian research suggests. The decreased risk was strongest for those who were taking the statins before their cancer diagnosis, investigators found. In addition, the study also showed, statin use was associated with a lower risk for any cause of death. MedicalXpress
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)